| __timestamp | Geron Corporation | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 16758000 | 20140000 |
| Thursday, January 1, 2015 | 17793000 | 37173000 |
| Friday, January 1, 2016 | 18761000 | 48616000 |
| Sunday, January 1, 2017 | 19287000 | 108488000 |
| Monday, January 1, 2018 | 18707000 | 244622000 |
| Tuesday, January 1, 2019 | 20893000 | 287000000 |
| Wednesday, January 1, 2020 | 25678000 | 354000000 |
| Friday, January 1, 2021 | 29665000 | 186000000 |
| Saturday, January 1, 2022 | 43628000 | 151000000 |
| Sunday, January 1, 2023 | 69135000 | 232600000 |
| Monday, January 1, 2024 | 267474000 |
Unleashing the power of data
In the competitive landscape of biotechnology, managing operational costs is crucial. Over the past decade, Ionis Pharmaceuticals and Geron Corporation have shown distinct trajectories in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Ionis Pharmaceuticals experienced a staggering 1,055% increase in SG&A costs, peaking in 2020. This reflects their aggressive expansion and investment in research and development. In contrast, Geron Corporation's SG&A expenses grew by 312% over the same period, indicating a more conservative growth strategy.
By 2023, Ionis's SG&A expenses were approximately 3.4 times higher than Geron's, highlighting their differing operational scales. These trends offer insights into each company's strategic priorities and market positioning. As the biotech industry continues to evolve, understanding these financial dynamics is essential for investors and stakeholders.
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Geron Corporation
Comparing SG&A Expenses: Intra-Cellular Therapies, Inc. vs Geron Corporation Trends and Insights
Bio-Techne Corporation and Ionis Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
BioMarin Pharmaceutical Inc. vs Geron Corporation: SG&A Expense Trends
Catalent, Inc. or Ionis Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Ionis Pharmaceuticals, Inc. vs Viking Therapeutics, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Ionis Pharmaceuticals, Inc. and Perrigo Company plc
Selling, General, and Administrative Costs: Ionis Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. and ImmunityBio, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Ionis Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Veracyte, Inc. and Geron Corporation
Cost Management Insights: SG&A Expenses for MorphoSys AG and Geron Corporation